𝔖 Bobbio Scriptorium
✦   LIBER   ✦

HLA antigens in north american patients with takayasu arteritis

✍ Scribed by Majed M. Khraishi; Dafna D. Gladman; Pierre Dagenais; Adel G. Fam; Edward C. Keystone

Publisher
John Wiley and Sons
Year
1992
Tongue
English
Weight
254 KB
Volume
35
Category
Article
ISSN
0004-3591

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Stent placement in a patient with Takaya
Stent placement in a patient with Takayasu's arteritis
✍ Ozdil, Erol ;Kumar Parikh, Dakshesh ;Krajcer, Zvonimir ;Angelini, Paolo πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 385 KB πŸ‘ 2 views

A 49-year-old woman with a history of Takayasu's arteritis underwent stent placement of the celiac and mesenteric arteries after unsuccessful balloon angioplasty. Stents may prove to be a beneficial alternative to angioplasty for treatment of the dense fibrotic leslons often associated with this dis

Limitations of therapy and a guarded pro
Limitations of therapy and a guarded prognosis in an american cohort of takayasu arteritis patients
✍ Kathleen Maksimowicz-McKinnon; Tiffany M. Clark; Gary S. Hoffman πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 231 KB πŸ‘ 1 views

## Abstract ## Objective To describe the clinical, laboratory, and radiographic manifestations of Takayasu arteritis (TA) in a cohort from the US, evaluate the response to interventions, remission and relapse rates, and disease progression, and compare these observations with those from other coho

Anti–tumor necrosis factor therapy in pa
Anti–tumor necrosis factor therapy in patients with difficult to treat Takayasu arteritis
✍ Gary S. Hoffman; Peter A. Merkel; Richard D. Brasington; Deborah J. Lenschow; Pa πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 240 KB πŸ‘ 2 views

## Abstract ## Objective Granulomatous inflammation is a typical feature of Takayasu arteritis (TA), and tumor necrosis factor (TNF) is important in the formation of granulomas. In this study, we assessed therapy with anti‐TNF agents in patients with TA that was not controlled by glucocorticoid th